Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrasekaran Padmapriyadarsini

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Mycobacteriology|September 8, 2021
Nontuberculous mycobacterium: An emerging pathogen: Indian perspectivePriya Rajendran, Chandrasekaran Padmapriyadarsini, Rajesh Mondal
The Indian Journal of Tuberculosis|September 15, 2024
Safety profile of BCG revaccination for COVID prevention among elderly individuals in IndiaBella Devaleenal Daniel, Mythily Venkatesan, Chandrasekaran Padmapriyadarsini, et al.
The Indian Journal of Tuberculosis|July 24, 2025
Drug resistant tuberculous meningitis: A neglected foe in ending tuberculosis epidemicLeeberk Raja Inbaraj, Bella Devaleenal Daniel, Chandrasekaran Padmapriyadarsini
Expert Review of Respiratory Medicine|December 11, 2020
The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countriesChandrasekaran Padmapriyadarsini, Kuldeep S Sachdeva, Dina Nair, et al.
Tropical Medicine and Infectious Disease|October 26, 2022
Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in IndiaMalaisamy Muniyandi, Nagarajan Karikalan, Banurekha Velayutham, et al.
The Indian Journal of Tuberculosis|December 8, 2025
Direct targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis from clinical samples - An updateRadha Gopalaswamy, Bhargavi Subramanian, Manisha Parthasarathy, et al.
Frontiers in Public Health|November 4, 2022
A national-level analysis of life expectancy associated with the COVID-19 pandemic in IndiaMalaisamy Muniyandi, Pravin Kumar Singh, Yamini Aanandh, et al.
The Indian Journal of Medical Research|January 11, 2026
Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TBMalaisamy Muniyandi, Karikalan Nagarajan, Karthick Chelvanayagam, et al.
International Health|August 2, 2024
Evaluating the cost-effectiveness of Cy-Tb for LTBI in India: a comprehensive economic modelling analysisMalaisamy Muniyandi, Karikalan Nagarajan, Kavi Mathiyazhagan, et al.
The Indian Journal of Medical Research|September 20, 2022
Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis diseaseBanurekha Velayutham, Kannan Thiruvengadam, Paramasivam Paul Kumaran, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Mycobacteriology|September 8, 2021
Nontuberculous mycobacterium: An emerging pathogen: Indian perspectivePriya Rajendran, Chandrasekaran Padmapriyadarsini, Rajesh Mondal
The Indian Journal of Tuberculosis|September 15, 2024
Safety profile of BCG revaccination for COVID prevention among elderly individuals in IndiaBella Devaleenal Daniel, Mythily Venkatesan, Chandrasekaran Padmapriyadarsini, et al.
The Indian Journal of Tuberculosis|July 24, 2025
Drug resistant tuberculous meningitis: A neglected foe in ending tuberculosis epidemicLeeberk Raja Inbaraj, Bella Devaleenal Daniel, Chandrasekaran Padmapriyadarsini
Expert Review of Respiratory Medicine|December 11, 2020
The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countriesChandrasekaran Padmapriyadarsini, Kuldeep S Sachdeva, Dina Nair, et al.
Tropical Medicine and Infectious Disease|October 26, 2022
Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in IndiaMalaisamy Muniyandi, Nagarajan Karikalan, Banurekha Velayutham, et al.
The Indian Journal of Tuberculosis|December 8, 2025
Direct targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis from clinical samples - An updateRadha Gopalaswamy, Bhargavi Subramanian, Manisha Parthasarathy, et al.
Frontiers in Public Health|November 4, 2022
A national-level analysis of life expectancy associated with the COVID-19 pandemic in IndiaMalaisamy Muniyandi, Pravin Kumar Singh, Yamini Aanandh, et al.
The Indian Journal of Medical Research|January 11, 2026
Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TBMalaisamy Muniyandi, Karikalan Nagarajan, Karthick Chelvanayagam, et al.
International Health|August 2, 2024
Evaluating the cost-effectiveness of Cy-Tb for LTBI in India: a comprehensive economic modelling analysisMalaisamy Muniyandi, Karikalan Nagarajan, Kavi Mathiyazhagan, et al.
The Indian Journal of Medical Research|September 20, 2022
Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis diseaseBanurekha Velayutham, Kannan Thiruvengadam, Paramasivam Paul Kumaran, et al.
Pageof 8